ATOS · Forms 3, 4, 5
Insider trades at ATOSSA THERAPEUTICS, INC.
No open-market insider buys or sells at ATOSSA THERAPEUTICS, INC. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for ATOSSA THERAPEUTICS, INC. (ATOS) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for ATOSSA THERAPEUTICS, INC. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Richard I Steinhart | Director | Award | 10,000 | Form 4 | |||
| Shu-Chih Chen | Director | Award | 10,000 | Form 4 | |||
| H. Lawrence Remmel | Director | Award | 10,000 | Form 4 | |||
| Jonathan Finn | Director | Award | 10,000 | Form 4 | |||
| Stephen J Galli | Director | Award | 10,000 | Form 4 | |||
| Tessa Cigler | Director | Award | 10,000 | Form 4 | |||
| Steven C Quay | President & CEO | Award | 65,000 | Form 4 | |||
| Mark James Daniel | Chief Financial Officer | Award | 63,000 | Form 4 | |||
| Steven C Quay | President & CEO | Award | 325,203 | Form 4 | |||
| Mark James Daniel | Chief Financial Officer | Options or other derivatives | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.